Pill for sleep apnea? trial tests new drug combo
NCT ID NCT03919955
Summary
This study tested whether a combination of two existing drugs (atomoxetine and oxybutynin) could reduce the severity of obstructive sleep apnea over one month of nightly use. Researchers compared the drug combo to a placebo in 48 adults with moderate-to-severe sleep apnea to see if it reduced breathing pauses and improved sleepiness and quality of life. A key goal was to identify which types of patients might benefit most from this potential non-device treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.